Neurosyphilis in HIV-infected patients: Clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis

Sexually Transmitted Diseases

Volumn 35, Issue 5, 2008, Pages 425-429

  Poliseli, Rodolfo ^a   Vidal, Jose E ^a,b   Penalva De Oliveira, Augusto C ^a,c   Hernandez, Adrian V ^d  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LABORATORY TEST; MALE; NEUROSYPHILIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; TITRIMETRY;

ADULT; BRAZIL; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROSYPHILIS; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD;

EID: 43449110134     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181623853     Document Type: Article

References (29)

1. Ciesielski CA. Sexually transmitted diseases in men who have sex with men: An epidemiologic review. Curr Infect Dis Rep 2003; 5:145-152.
2. Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis 2000; 27:53-59.
3. Sutmoller F, Penna TL, de Souza CT, et al; Oswaldo Cruz Foundation STD/HIV Prevention Group. Human immunodeficiency virus incidence and risk behavior in the "Projeto Rio": Results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98. Int J Infect Dis 2002; 6:259-265.
4. Rodrigues EH, Abath FG. Sexually transmitted diseases in patients infected with HIV/AIDS in the State of Pernambuco, Brazil. Rev Soc Bras Med Trop 2000; 33:47-52.
5. Marra CM. Neurosyphilis. Curr Neurol Neurosci Rep 2004; 4:435-440.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1-94.
7. Vidal-Bermudez JE, Bonasser-Filho F, Schiavon-Nogueira R. Syphilitic meningomyelitis in a patient with AIDS. Rev Neurol 2004; 38:998-999.
8. Deleted in proof.
9. Trujillo JR, Jaramillo-Rangel G, Ortega-Martinez M, et al. International NeuroAIDS: Prospects of HIV-1 associated neurological complications. Cell Res 2005; 15:962-969.
10. de Oliveira JF, Greco DB, Oliveira GC, et al. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: A Brazilian experience. Rev Soc Med Trop 2006; 39:146-151.
11. Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy. Am J Med 1995; 99:55-63.
12. Marra MC. Neurosyphilis. In: Scheld WM, Whitley RJ, Marra CM, eds. Infectious of the Central Nervous System. Philadelphia: Lippincott, Williams & Wilkins, 2004:649-658.
13. Musher DM. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 1991; 163:1201-1206.
14. Vidal JE, Hernandez AV, Penalva de Oliveira AC, et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: Clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDs 2005; 19:840-848.
15. Deleted in proof.
16. Merrit HH, Adams RD, Solomon HC. Neurosyphilis. New York: Oxford, 1946.
17. Berger JR. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals: A prospective study. Arch Neurol 1991; 48:700-722.
18. Katz DA, Berger JR, Duncan RC. Neurosyphilis: A comparative study of the effects of infection with human immunodeficiency virus [published erratum in Arch Neurol 1993; 50:614]. Arch Neurol 1993; 50:243-249.
19. de Souza MC, Nitrini R. Effects of human immunodeficiency virus infection on the manifestations of neurosyphilis. Neurology 1997; 49:893-894.
20. Berger JR. Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy. Am J Med 1992; 92:101-103.
21. Zetola NM, Klausner JD. Syphilis and HIV infection: An update. Clin Infect Dis 2007; 44:1222-1228.
22. Centers for Disease Control and Prevention. Symptomatic early neurosyphilis among HIV-positive men who have sex with men - Four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007; 56:625-628.
23. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189:369-376.
24. Libois A, de Wit S, Poll B, et al. HIV and syphilis: When to perform a lumbar puncture. Sex Transm Dis 2007; 34:141-144.
25. Zetola NM, Engelman J, Jensen TP, et al. Syphilis in the United States: An update for clinicians with an emphasis on HIV infection. Mayo Clin Proc 2007; 82:1091-1102.
26. Rolfs RT, Joesoef MR, Hendershot EF, et al; Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with or without human immunodeficiency virus infection. N Engl J Med 1997; 337:307-314.
27. Marra C. Déjà vu all over again: when to perform a lumbar puncture in HIV-infected patients with syphilis. Sex Transm Dis 2007; 34:145-146.
28. Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988; 45:954 -958.
29. Marra CM, Maxwell CL, Tantalo L, et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter?. Clin Infect Dis 2004; 38:1001-1006.